Results

Total Results: 1,524 records

Showing results for "drugs".

381. Crosscutting Hi Impact (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting_hi_impact.pdf
     January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … It differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.

382. Antipsychotics for the Prevention and Treatment of Delirium: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
     June 01, 2018 - have been diagnosed with delirium using a validated instrument • Interventions: o Antipsychotic drugs … , risperidone, ziprasidone) o We will only include studies where the effects of the antipsychotic drugs … quetiapine, risperidone, ziprasidone) • We will exclude studies where the effects of the antipsychotic drugs

383. App-F1-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
     October 08, 2025 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…

384. Fibromyalgia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
     January 01, 2015 - Treatment components may include drugs, exercise programs, cognitive behavioral therapy (CBT), patient … In addition, numerous drugs approved for other conditions are currently used off label in patients … Pharmacolgic, nonpharmocologic, or multimodal treatments Adverse effects of drugs or interventions … We excluded studies of drugs not FDA approved in the United States for any condition; studies that … Subgroup Outcomes In this section, we first examine the effect of drugs on various subgroups and then

385. Tonsillectomy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
     February 10, 2016 - role  of   perioperative  anti-­inflammatory  medications  (e.g.,  non-­steroidal  anti-­inflammatory  drugs … Appendix  A   outlines  manufacturers  of  key  device  and  drugs  used  to  treat  the  population   … or  obstructive  sleep-­disordered   breathing  may  include  use  of  the  following  classes  of  drugs … Some  drugs  are  not  recommended  in  younger   children  (e.g.,  diphenhydramine)  as  they  may   … Leukotriene  inhibitors:  These  drugs  are  FDA-­approved  to  treat  asthma  symptoms  in  children

386. Systematic Review on Treatments for Acute Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
     May 01, 2022 - Opioid therapy versus nonopioid pharmacologic therapy (acetaminophen, non-steroidal anti-inflammatory drugs … CNS Drugs. 2021;35(1):105-20. doi: 10.1007/s40263- 020-00777-7. PMID: 33428176. … The treatment of topical drugs for postherpetic neuralgia: a network meta-analysis. … Canadian Agency for Drugs and Technologies in Health. 2021 PMID: 34185448. … Non-steroidal anti- inflammatory drugs for acute low back pain.

387. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - infected blood.4 The most common mode of HCV transmission in the United States is the use of injection drugs … These new agents may be used in combination with existing antiviral drugs, and the duration of treatment … ribavirin and interferon doses, taking greater than 80 percent of the required dosage of one or both drugs … Additionally, we will request Scientific Information Packets from manufacturers of relevant drugs, devices … We will record the generic names of the drugs used to treat the intervention and control groups, dose

388. Quantitative Synthesis II: Interactive Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
     October 08, 2025 - good source of information for planning future research and may provide some preliminary data on new drugs

389. Quantitative Synthesis II: Interactive Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
     October 08, 2025 - good source of information for planning future research and may provide some preliminary data on new drugs

390. Updating Current Effectiveness Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
     September 15, 2008 - conduct and support research on the comparative outcomes, clinical effectiveness, and appropriateness of pharmaceuticals … support research with a focus on outcomes, comparative clinical effectiveness, and appropriateness of pharmaceuticals … MedWatch database and the Canadian Health Services (CHS) pharmaceutical database for any reports about drugs

391. Management of Acute Diverticulitis Additional Information for Topic Nomination (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-nomination-extra.pdf
     October 08, 2025 - Management of Acute Diverticulitis Additional Information for Topic Nomination Table 1. Key Questions and PICOTS KQ1: Antibiotics KQ1: Antibiotics vs. No Antibiotics KQ2: Diagnostic imaging KQ3: Follow-up colonoscopy KQ4: Surgical and interventional management KQ5: Prevention of recurrence Populat…

392. EHC Protocol: Making Healthcare Safer IV: Deprescribing to Reduce Medication Harms in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
     July 01, 2023 - approach, known as deprescribing, is defined as a “systematic process of identifying and discontinuing drugs … Drugs Aging. 2013 Oct;30(10):793-807. doi: 10.1007/s40266-013-0106-8. PMID: 23912674. 10.

393. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
     October 01, 2021 - preferred treatment of chronic pain.1,2 However, recent systematic reviews found that several nonopioid drugs … qualitative and indirect comparisons with very limited evidence on cannabis products relative to the other drugs

394. Searching for Relevant Studies (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
     January 01, 2011 - Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. … or may be incompletely published elsewhere Good check for publication bias Regulatory Web sites: Drugs … That is because the approval process for new drugs and devices requires submission of data that may not … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. Sassi F, Archard L, McDaid D. 

395. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
     February 22, 2012 - Tinnitus can also be a side effect of potentially ototoxic drugs, ranging from aspirin taken to alleviate … arthritic pain to aminoglycoside antibiotics and life-saving drugs used to treat cancer.4 These effects … While drugs are used for tinnitus, there is no drug that has been approved specifically for its treatment … Behavioral methods should be used before considering the use of drugs. … Drugs can be used to treat comorbid conditions such as anxiety and depression.

396. DARTNet Summary Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
     July 01, 2009 - (cross-walked) to one of several coding systems; ICD-9 CM for diagnoses, RxNORM and GCN codes for drugs … of SNOMED CT versus commercially available drug codes for group classifications and combination drugs … the DARTNet Diabetes Replication Cohort was generally similar to those seen in phase 1 related to drugs … study will describe the patterns of use of antidepressants and combinations of other psychotropic drugs … research, DARTNet’s ultimate aim is to improve the understanding of the effectiveness of various drugs

397. Appendix A. Long COVID Models of Care – Grey literature sources (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-appendix-a.pdf
     December 01, 2022 - Physical Medicine & Rehabilitation; ACC = American College of Cardiology; CADTH = Canadian Agency for Drugs

398. App-F2-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
     October 08, 2025 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

399. Future Research Needs Document (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
     October 25, 2010 - conduct and support research on the comparative outcomes, clinical effectiveness, and appropriateness of pharmaceuticals … Drugs based on a person's genetics 37.5% (3) 50.0% (4) 12.5% (1) Q12. … Gene-based drugs 54.5% (6) 9.1% (1) 36.4% (4) Q12. … Drugs that target specific molecular cancer pathways 62.5% (5) 37.5% (3) 0 (0) Q13. … Randomized controlled trials I Drug development 224 Molecular targeted drugs specific to

400. Appendix C: Fiber Intake and Laxation in People With Normal Bowel Function Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
     January 01, 2024 - health legume allergy; milk or lactose intolerance; chronic diseases; pregnancy; lactation; intake of pharmaceuticals … lactose intolerance, chronic bowel diseases, pregnancy, lactation, and the intake of blood lipid–lowering pharmaceuticals … funding of study NR 18–55 years, BMI: 18.5-30 kg/m2, healthy and free of chronic diseases, avoid any pharmaceuticals … Antibiotics, anti-inflammatory/immune suppressive drugs and spasmolytics use.* (e.g. hospital or nursing … Antibiotics, anti-inflammatory/immune suppressive drugs and spasmolytics use. 4 wk 4-6 wk 28/28 d Days